FK506 in the treatment of inflammatory skin disease: Promises and perspectives
FK506 in the treatment of inflammatory skin disease: Promises and perspectives
复制标题
DOI：
10.1016/0167-5699(96)80599-8
复制
发表时间：
1996-03-01
期刊：
影响因子：
--
通讯作者：
Ruzicka, T
中科院分区：
文献类型：
--
作者：
Michel, G;Kemeny, L;Ruzicka, T
免疫抑制大环内酯类药物Fk505目前在皮肤药理学中越来越重要。在这里，Gunter Michel和他的同事总结了这种药物对T细胞以外的细胞类型，特别是表皮细胞的功能调节的分子机制的研究现状。
The immunosuppressive macrolide drug Fk505 is currently gaining increasing importance in dermatopharmacology. Here, Gunter Michel and colleagues summarize the current state of research info tire molecular mechanisms responsible for the functional modulation of cell type other than T cells, particularly epidermal cells, by this drug.